Cowen Financial Products LLC 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 12:22 pm Sale | 2024-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Cowen Financial Products LLC | 1,909,228 4.900% | -2,171 (-0.11%) | Filing |
| 2024-02-02 12:40 pm Purchase | 2023-12-29 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Cowen Financial Products LLC | 1,911,399 5.770% | 512,416 (+36.63%) | Filing |
| 2023-05-05 3:28 pm Purchase | 2023-04-28 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Cowen Financial Products LLC | 1,398,983 5.220% | 1,398,983 (New Position) | Filing |